PlainRecalls
FDA Drug Low Class III Terminated

Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. UPC 368462583401. NDC 68462-583-40

Reported: December 26, 2018 Initiated: November 27, 2018 #D-0349-2019

Product Description

Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. UPC 368462583401. NDC 68462-583-40

Reason for Recall

Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.

Details

Units Affected
5,016 blister packs
Distribution
Nationwide
Location
Mahwah, NJ

Frequently Asked Questions

What product was recalled?
Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. UPC 368462583401. NDC 68462-583-40. Recalled by Glenmark Pharmaceuticals Inc., USA. Units affected: 5,016 blister packs.
Why was this product recalled?
Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 26, 2018. Severity: Low. Recall number: D-0349-2019.